Vicente
Soriano Vazquez
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (64)
2024
-
The incidence of HIV-2 infection in Spain is declining – a registry data analysis
International Journal of Infectious Diseases, Vol. 146
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis
International Journal of Infectious Diseases, Vol. 131, pp. 173-179
-
HTLV-1-associated myelopathy in Spain
Journal of Clinical Virology, Vol. 169
-
Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain
Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548
-
Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain
Journal of Clinical Virology, Vol. 167
2022
-
Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies
Journal of Viral Hepatitis, Vol. 29, Núm. 9, pp. 777-784
-
Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network
International Journal of Infectious Diseases, Vol. 122, pp. 970-975
-
Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain
Hepatology International, Vol. 16, Núm. 5, pp. 1161-1169
2021
-
Hepatitis delta in patients hospitalized in Spain (1997-2018)
AIDS (London, England), Vol. 35, Núm. 14, pp. 2311-2318
2019
-
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
-
Predictors of hepatitis C treatment failure after using direct-acting antivirals in people living with human immunodeficiency virus
Open Forum Infectious Diseases, Vol. 6, Núm. 3
2018
-
Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
Open Forum Infectious Diseases, Vol. 5, Núm. 1
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
2016
-
IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection
Liver International, Vol. 36, Núm. 9, pp. 1258-1266
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596